| Dr Sunil Gangwani, MD | |
|
1176 Town And Country Commons Dr, Chesterfield, MO 63017-8200 | |
| (314) 251-2870 | |
| (314) 251-2871 |
| Full Name | Dr Sunil Gangwani |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 20 Years |
| Location | 1176 Town And Country Commons Dr, Chesterfield, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902004203 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinic Adult Psychiatry Llc | 4688998602 | 15 |
News Archive
Researchers have shown that a new nuclear medicine procedure could safely and more effectively detect cancerous gastrointestinal and pancreatic neuroendocrine tumors than current methods.
Cancer cells consume exorbitant amounts of glucose, a key source of energy, and shutting down this glucose consumption has long been considered a logical therapeutic strategy.
Nurses, occupational and physical therapists, case managers and education staff, all working together at a 300-bed Nebraska rehabilitation hospital, have successfully implemented a team approach to dramatically reduce infections from urinary catheters, the most prevalent type of infection acquired in healthcare settings.
Takeda Pharmaceutical Company Limited today announced results from the TOURMALINE-MM1 trial presented at the 57th Annual Meeting and Exposition of the American Society of Hematology (ASH), showing that treatment with NINLARO (ixazomib) capsules is effective in extending progression free survival (PFS) with a manageable tolerability profile in patients with relapsed and/or refractory multiple myeloma.
› Verified 4 days ago
| Entity Name | Mercy Clinic Adult Psychiatry Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750788972 PECOS PAC ID: 4688998602 Enrollment ID: O20150122002258 |
News Archive
Researchers have shown that a new nuclear medicine procedure could safely and more effectively detect cancerous gastrointestinal and pancreatic neuroendocrine tumors than current methods.
Cancer cells consume exorbitant amounts of glucose, a key source of energy, and shutting down this glucose consumption has long been considered a logical therapeutic strategy.
Nurses, occupational and physical therapists, case managers and education staff, all working together at a 300-bed Nebraska rehabilitation hospital, have successfully implemented a team approach to dramatically reduce infections from urinary catheters, the most prevalent type of infection acquired in healthcare settings.
Takeda Pharmaceutical Company Limited today announced results from the TOURMALINE-MM1 trial presented at the 57th Annual Meeting and Exposition of the American Society of Hematology (ASH), showing that treatment with NINLARO (ixazomib) capsules is effective in extending progression free survival (PFS) with a manageable tolerability profile in patients with relapsed and/or refractory multiple myeloma.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sunil Gangwani, MD 1176 Town And Country Commons Dr, Chesterfield, MO 63017-8200 Ph: (314) 251-2870 | Dr Sunil Gangwani, MD 1176 Town And Country Commons Dr, Chesterfield, MO 63017-8200 Ph: (314) 251-2870 |
News Archive
Researchers have shown that a new nuclear medicine procedure could safely and more effectively detect cancerous gastrointestinal and pancreatic neuroendocrine tumors than current methods.
Cancer cells consume exorbitant amounts of glucose, a key source of energy, and shutting down this glucose consumption has long been considered a logical therapeutic strategy.
Nurses, occupational and physical therapists, case managers and education staff, all working together at a 300-bed Nebraska rehabilitation hospital, have successfully implemented a team approach to dramatically reduce infections from urinary catheters, the most prevalent type of infection acquired in healthcare settings.
Takeda Pharmaceutical Company Limited today announced results from the TOURMALINE-MM1 trial presented at the 57th Annual Meeting and Exposition of the American Society of Hematology (ASH), showing that treatment with NINLARO (ixazomib) capsules is effective in extending progression free survival (PFS) with a manageable tolerability profile in patients with relapsed and/or refractory multiple myeloma.
› Verified 4 days ago
Amy C Rauchway, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1176 Town And Country Commons, Chesterfield, MO 63017 Phone: 636-893-1260 Fax: 636-893-1261 | |
Dr. Frasat Chaudhry, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 232 S Woods Mill Rd, 400 East, Chesterfield, MO 63017 Phone: 314-878-2888 Fax: 314-576-8167 | |
Dr. Todd Brook Silverman, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 14825 North Outer 40 Rd Ste 330-b, Chesterfield, MO 63017 Phone: 636-537-0525 Fax: 636-537-0575 | |
Dr. Beth Ann Ward, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 232 S Woods Mill Rd, Sleep Medicine, Chesterfield, MO 63017 Phone: 314-205-6030 Fax: 314-338-7157 | |
Katherine P. Buchowski, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 15455 Conway Rd Ste 117, Chesterfield, MO 63017 Phone: 314-388-9855 Fax: 314-470-6997 | |
Patti M Nemeth, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 232 S Woods Mill Rd, Suite 400 East, Chesterfield, MO 63017 Phone: 314-878-2888 Fax: 314-576-8167 | |
Savita S. Bhat, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 167 Lamp And Lantern Vlg Ste 292, Chesterfield, MO 63017 Phone: 314-736-5575 Fax: 314-736-5576 |